Clinical Trial Update: A Research Study to Evaluate MK0653 (Ezetimibe) and Simvastatin, Given Together and Alone, on Intestinal Absorption of Cholesterol (0653-050)(COMPLETED) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating ezetimibe (MK0653) with and without simvastatin on intestinal absorption of cholesterol has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• EZETIMIBE (EZETIMIBE)
• SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: Organon and Co | Conditions: Cholesterol | Phase 3 | Status: COMPLETED